These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 10479395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 3. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop.
    Nagata M, Kotani R, Moriyama H, Yokono K, Roep BO, Peakman M.
    Ann N Y Acad Sci; 2004 Dec; 1037():10-5. PubMed ID: 15699487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.
    Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, Roep BO, Second International Immunology of Diabetes Society Workshop for Standardization ot T-cell Assays in Type 1 Diabetes.
    Diabetes; 2001 Aug; 50(8):1749-54. PubMed ID: 11473034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
    Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schröder S, Seissler J, Scherbaum WA, Kalbacher H.
    Exp Clin Endocrinol Diabetes; 1999 Aug; 107(3):166-71. PubMed ID: 10376440
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [Abstract] [Full Text] [Related]

  • 11. Immunomodulation with human recombinant autoantigens.
    Lernmark A, Agardh CD.
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [Abstract] [Full Text] [Related]

  • 12. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC.
    J Immunol; 2010 Feb 15; 184(4):2204-10. PubMed ID: 20083660
    [Abstract] [Full Text] [Related]

  • 13. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E, Lampasona V, Bingley PJ.
    J Immunol; 1998 Sep 01; 161(5):2648-54. PubMed ID: 9725268
    [Abstract] [Full Text] [Related]

  • 14. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK, Vaarala O, Thuswaldner S, Ilonen J, Hinkkanen A, Ludvigsson J.
    Diabetes Metab Res Rev; 2006 Sep 01; 22(6):462-70. PubMed ID: 16572494
    [Abstract] [Full Text] [Related]

  • 15. Modulation of autoimmunity to beta-cell antigens by proteases.
    Roep BO, van den Engel NK, van Halteren AG, Duinkerken G, Martin S.
    Diabetologia; 2002 May 01; 45(5):686-92. PubMed ID: 12107749
    [Abstract] [Full Text] [Related]

  • 16. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q, Borovitskaya AE, DeSilva MG, Wasserfall C, Maclaren NK, Notkins AL, Lan MS.
    Proc Assoc Am Physicians; 1997 Jul 01; 109(4):429-39. PubMed ID: 9220540
    [Abstract] [Full Text] [Related]

  • 17. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y, Kawasaki E, Abiru N, Ozaki M, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K.
    J Autoimmun; 1999 Sep 01; 13(2):257-65. PubMed ID: 10479394
    [Abstract] [Full Text] [Related]

  • 18. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S, Willis J, Maclean C, Ananieva-Jordanova R, Amoroso MA, Brooking H, Powell M, Collins A, Bennett S, Mitchell S, Burne P, Furmaniak J, Smith BR.
    Clin Chim Acta; 2005 Jul 01; 357(1):74-83. PubMed ID: 15963796
    [Abstract] [Full Text] [Related]

  • 19. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
    Zhang YJ, Chen HL, Yu LP, Han XY.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec 28; 25(6):545-7. PubMed ID: 12516400
    [Abstract] [Full Text] [Related]

  • 20. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
    Schloot NC, Roep BO, Wegmann DR, Yu L, Wang TB, Eisenbarth GS.
    Diabetologia; 1997 Mar 28; 40(3):332-8. PubMed ID: 9084973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.